Nasus Pharma Ltd
NSRX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002029039
No open-market purchases or sales by Nasus Pharma Ltd insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $7.53M in total; no superinvestor holds it.
Holders of 5% or more of NSRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nasus Pharma Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Gilboa Udi | 13G | 21.10%1.90M shares | New | Nov 10, 20251 filing | Nov 10, 2025 | SEC |
| Megiddo Dalia | 13G | 20.90%1.89M shares | New | Nov 12, 20251 filing | Nov 12, 2025 | SEC |
| Hershman Ronnie | 13G | 15.30%1.38M shares | New | Nov 13, 20251 filing | Nov 13, 2025 | SEC |
| Balyasny Asset Management LLC | 13G/A | 9.99%1.17M shares | 0.00 ppfrom 9.99% | May 15, 20262 filings | Aug 14, 2026 | SEC |
| Capital Point Ltd. | 13G | 6.35%575.1K shares | New | Aug 20, 20251 filing | Aug 20, 2025 | SEC |
| Funicular Funds, LP | 13G | 5.20%612.9K shares | New | Apr 7, 20261 filing | Apr 7, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on Nasus Pharma Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20266:06 AM ET | Balyasny Asset Management LLCand 4 others | 13G/A | 9.99%1.17M shares | 0.00 ppfrom 9.99% | Jun 30, 2026 | SEC |
| May 15, 20266:12 AM ET | Balyasny Asset Management LLCand 4 others | 13G | 9.99%1.17M shares | New | Mar 31, 2026 | SEC |
| Apr 7, 20265:12 PM ET | Funicular Funds, LPand 2 others | 13G | 5.20%612.9K shares | New | Mar 31, 2026 | SEC |
| Nov 13, 20259:29 AM ET | Hershman Ronnieand 1 other | 13G | 15.30%1.38M shares | New | Sep 30, 2025 | SEC |
| Nov 12, 20254:05 PM ET | Megiddo Dalia | 13G | 20.90%1.89M shares | New | Sep 30, 2025 | SEC |
| Nov 10, 20255:05 PM ET | Gilboa Udi | 13G | 21.10%1.90M shares | New | Sep 30, 2025 | SEC |
| Aug 20, 20254:55 PM ET | Capital Point Ltd. | 13G | 6.35%575.1K shares | New | Aug 14, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nasus Pharma Ltd shares.
No Form 144 notices for Nasus Pharma Ltd are on file.